A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

BACKGROUND Bacterial endocarditis is a serious disease. Surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) based on serum protein profiling is a powerful approach that can generate biomarkers with diagnostic value. METHODS To identify a protein signature associated with bacterial endocarditis, we retrospectively performed SELDI-TOF MS profiling of serum samples from 88 patients hospitalized because of clinical suspicion of endocarditis. The diagnosis was confirmed by conventional criteria for 34 patients (endocarditis positive) and was excluded for 54 patients (endocarditis negative). Serum samples were incubated with cation-exchange ProteinChip arrays. The protein profiles generated were subjected to biostatistical processing. RESULTS Fifty-nine samples (23 endocarditis positive and 36 endocarditis negative) were randomly selected for a learning set, with the 29 remaining samples (11 endocarditis positive and 18 endocarditis negative) serving as an independent testing (validation) set. Sixty-six protein peaks were differentially expressed between the endocarditis-positive and the endocarditis-negative patients. By combining partial least squares and logistic regression methods, we built a serum protein model that perfectly discriminated between endocarditis-positive and endocarditis-negative patients. Importantly, when this model was tested on the independent testing set, a correct prediction rate of nearly 90% was demonstrated. Overall, sensitivity, specificity, positive predictive value, and negative predictive value were 94%, 98%, 96%, and 96%, respectively. CONCLUSIONS SELDI-TOF MS profiling revealed a serum signature with high diagnostic potential for endocarditis.

[1]  杜昕,et al.  Infective endocarditis , 2007 .

[2]  F. Bertucci,et al.  Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy , 2006, Oncogene.

[3]  Graham Ball,et al.  New approaches to identification of bacterial pathogens by surface enhanced laser desorption/ionization time of flight mass spectrometry in concert with artificial neural networks, with special reference to Neisseria gonorrhoeae. , 2005, Journal of medical microbiology.

[4]  D. Raoult,et al.  Contribution of Systematic Serological Testing in Diagnosis of Infective Endocarditis , 2005, Journal of Clinical Microbiology.

[5]  O John Semmes,et al.  SELDI‐TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma , 2005, Hepatology.

[6]  Jeffrey S. Morris,et al.  Serum proteomics profiling—a young technology begins to mature , 2005, Nature Biotechnology.

[7]  M. Forsman,et al.  Discrimination of Francisella tularensis subspecies using surface enhanced laser desorption ionization mass spectrometry and multivariate data analysis. , 2005, FEMS microbiology letters.

[8]  Jean-Charles Sanchez,et al.  Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob disease , 2004, Proteomics.

[9]  Robert Tibshirani,et al.  The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers , 2004, Clinical Cancer Research.

[10]  O. John Semmes,et al.  SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers , 2004, Disease markers.

[11]  D. Morton,et al.  Detection of Differentially Expressed Proteins in Early‐Stage Melanoma Patients Using SELDI‐TOF Mass Spectrometry , 2004, Annals of the New York Academy of Sciences.

[12]  M. Sammel,et al.  A Serum Proteomics Approach to the Diagnosis of Ectopic Pregnancy , 2004, Annals of the New York Academy of Sciences.

[13]  Zhaosheng Lin,et al.  Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma , 2004, Modern Pathology.

[14]  Timothy Planche,et al.  A novel and accurate diagnostic test for human African trypanosomiasis , 2004, The Lancet.

[15]  Fumio Nomura,et al.  Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization‐mass spectrometry , 2004, Proteomics.

[16]  D. Ransohoff.  Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.

[17]  T. Colgan,et al.  Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. , 2004, Journal of proteome research.

[18]  D. Chan,et al.  Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry , 2004, Clinical Cancer Research.

[19]  D. Raoult,et al.  Mycoplasma endocarditis: two case reports and a review. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  T. Kang,et al.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons , 2003, Proteomics.

[21]  M. Ferrari,et al.  Clinical proteomics: Written in blood , 2003, Nature.

[22]  D. Hochstrasser,et al.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.

[23]  L. Olaison,et al.  A Clinical Study of Culture-Negative Endocarditis , 2003, Medicine.

[24]  T. Zhukov,et al.  Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. , 2003, Lung cancer.

[25]  T. Yip,et al.  Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. , 2003, Clinical chemistry.

[26]  Sophie Lambert-Lacroix,et al.  Effective dimension reduction methods for tumor classification using gene expression data , 2003, Bioinform..

[27]  E. Petricoin,et al.  Serum proteomic patterns for detection of prostate cancer. , 2002, Journal of the National Cancer Institute.

[28]  Danh V. Nguyen,et al.  Multi-class cancer classification via partial least squares with gene expression profiles , 2002, Bioinform..

[29]  Douglas C Pearl,et al.  Proteomic patterns in serum and identification of ovarian cancer , 2002, The Lancet.

[30]  F. Alla,et al.  Changing profile of infective endocarditis: results of a 1-year survey in France. , 2002, JAMA.

[31]  P. Schellhammer,et al.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.

[32]  D. Raoult,et al.  Changing clinical presentation of Q fever endocarditis. , 2002, Clinical Infectious Diseases.

[33]  D. Raoult,et al.  Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  曽川 一幸.  Identification of novel and down-regulated biomarkers for alcoholism by surface enhanced laser desorption/ionization mass spectrometry , 2005 .

[36]  Bodo E. Knudsen,et al.  Surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry (SELDI‐TOF‐MS): A new proteomic urinary test for patients with urolithiasis , 2004, Journal of clinical laboratory analysis.

[37]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[38]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.